Resorcinol
Active ingredient · 2 therapeutic classes
Sold as Equate Vagicaine
- Drug class
- Other Anti-Acne Preparations For Topical Use
- Availability
- Over-the-counter
- Routes
- Topical
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Resorcinol is a topical preparation used for other anti-acne treatments [1]. It is approved to temporarily relieve itching [1].
This active ingredient is available under various brand names, including Equate Vagicaine [1]. In the past 12 months, there has been 1 adverse event report associated with this ingredient [2]. The most frequent reactions reported include complications associated with devices, COVID-19, diarrhea, Enterobacter infections, and flatulence [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 3, 2024 |
USUnited States· FDA
1 product
Uses
Uses Temporarily Relieves Itching
How to take
Drug interactions
Known interactions involving Resorcinol. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 0cdc9323-f5c3-46… · revised January 3, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.